VEGFA and retinal disorder: While these may still have a limited role in the management of retinal disorders, the advent of intravitreal therapy specifically targeting VEGF-A has revolutionized the treatment of such disorders, providing rapid and sustained improvements in VA alongside favorable side-effect profiles.